Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

63.51
Delayed Data
As of 4:00pm ET
 +0.29 / +0.46%
Today’s Change
58.29
Today|||52-Week Range
66.80
+7.88%
Year-to-Date

Today’s Trading

Previous close63.22
Today’s open64.09
Day’s range63.41 - 64.11
Volume7,880,769
Average volume (3 months)8,055,651
Market cap$172.4B
Dividend yield2.96%
Data as of 4:00pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+2.43%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+1.86%
P/E ratio34.3
Price/Sales4.15
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.30-0.35%
PFEPfizer-0.37-1.02%
SNYSanofi-0.06-0.12%
ABBVAbbVie+3.87+4.20%
Data as of 4:02pm ET, 10/18/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts